Loading insider details...
Beta
Latest Form 4 (Oct 19, 2026): Grant/Award of 22,649 CTY shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 19, 2026 | CITY THERAPEUTICS, INC. (CTY) | Grant/Award | 22,649 | n/a |
| Jun 23, 2026 | Dyne Therapeutics, Inc. (DYN) | Grant/Award | 57,463 | n/a |
| May 26, 2026 | Karyopharm Therapeutics Inc. (KPTI) | Grant/Award | 15,508 | n/a |
| May 29, 2025 | Karyopharm Therapeutics Inc. (KPTI) | Grant/Award | 4,600 | n/a |
| Aug 7, 2024 | Sage Therapeutics, Inc. (SAGE) | Grant/Award | 50,400 | n/a |
| May 30, 2024 | Karyopharm Therapeutics Inc. (KPTI) | Grant/Award | 69,000 | n/a |
| Feb 15, 2024 | Sage Therapeutics, Inc. (SAGE) | Grant/Award | 168,000 | n/a |
| May 25, 2023 | Karyopharm Therapeutics Inc. (KPTI) | Grant/Award | 34,000 | n/a |
| Aug 15, 2022 | Karyopharm Therapeutics Inc. (KPTI) | Exercise/Conversion | 7,576 | $11.3K |
| May 20, 2022 | Karyopharm Therapeutics Inc. (KPTI) | Grant/Award | 23,900 | n/a |